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Obese patients are more likely to develop periprosthetic joint infection (PJI) after primary
total joint arthroplasty. This study compared the clinical and microbiological characteristics
of non-obese, obese and severely obese patients with early PJI, in order to ultimately opti-
mize antibiotic prophylaxis and other prevention measures for this specific patient category.
Methods
We retrospectively evaluated patients with early PJI of the hip and knee treated with
debridement, antibiotics and implant retention (DAIR) between 2006 and 2016 in three
Dutch hospitals. Only patients with primary arthroplasties indicated for osteoarthritis were
included. Early PJI was defined as an infection that developed within 90 days after index sur-
gery. Obesity was defined as a BMI�30kg/m2 and severe obesity as a BMI�35kg/m2.
Results
A total of 237 patients were analyzed, including 64 obese patients (27.0%) and 62 severely
obese patients (26.2%). Compared with non-obese patients, obese patients had higher
rates of polymicrobial infections (60.3% vs 33.3%, p<0.001) with more often involvement of
Enterococcus species (27.0% vs 11.7%, p = 0.003). Moreover, severely obese patients had
more Gram-negative infections, especially with Proteus species (12.9% vs 2.3%, p =
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0.001). These results were only found in periprosthetic hip infections, comprising Gram-neg-
ative PJIs in 34.2% of severely obese patients compared with 24.7% in obese patients and
12.7% in non-obese patients (p = 0.018).
Conclusions
Our results demonstrate that obese patients with early periprosthetic hip infections have
higher rates of polymicrobial infections with enterococci and Gram-negative rods, which
stresses the importance of improving preventive strategies in this specific patient category,
by adjusting antibiotic prophylaxis regimens, improving disinfection strategies and optimiz-
ing postoperative wound care.
Introduction
Obesity is a major health concern worldwide, as obesity has nearly tripled in the last decades.
Currently, 39% of adults are overweight and 13% are obese [1]. Obesity is not only associated
with an increased risk of comorbidities, such as hypertension, diabetes mellitus and ischaemic
heart disease [2], but due to early development of osteoarthritis of weight bearing joints, obese
patients are also more likely to receive joint arthroplasty [3]. Implantation of joint arthroplas-
ties may lead to postoperative complications, particularly in obese patients [4]. The most
important complication is periprosthetic joint infection (PJI), occurring in approximately
1–2% of patients receiving joint arthroplasty [5]. PJI has a large impact on patient’s quality of
life and is accompanied by high healthcare costs. Literature indicates that the risk of PJI
increases exponentially with the body mass index (BMI): i.e. severely obese patients have a
four times increased risk of PJI compared with non-obese patients [6, 7].
There are many hypotheses for the increased risk of PJI in obese patients [8]. First of all,
obese patients are prone to diminished wound healing because of increased surface tension at
the surgical site and prolonged wound leakage due to bulky subcutaneous tissue [9]. Secondly,
higher glucose levels in obese patients with diabetes mellitus increase the risk of infection [10].
Thirdly, the applied cefazolin dosage as antibiotic prophylaxis may not be sufficient to achieve
adequate tissue concentrations in obese patients, especially in patients weighing more than
120kg or with a BMI >40kg/m2 [11–13]. Finally, obese patients have increased bacterial colo-
nization of the skin compared with non-obese patients, particularly in the groin [14, 15]. Cur-
rently applied antibiotic prophylaxis may not provide full coverage for these microorganisms.
To optimize prevention measures for obese patients receiving primary total joint arthro-
plasty, we aimed to describe the clinical and microbiological characteristics of early PJI in
obese and severely obese patients.
Patients and methods
Study design
We retrospectively reviewed patients with early PJI of the hip and knee who were treated with
debridement, antibiotics and implant retention (DAIR) in one university hospital (University
Medical Center Groningen) and two general hospitals (Martini Hospital and Medical Center
Leeuwarden) between January 2006 and December 2016. PJI was diagnosed according to the
diagnostic criteria defined by the Musculoskeletal Infection Society (MSIS) [16]. In case of a
single positive culture with a highly virulent microorganism, PJI was diagnosed in consultation
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with the infectious diseases specialist or medical microbiologist. Early PJI was defined as an
infection developed within 90 days after index surgery [17]. Only patients with primary arthro-
plasties indicated for osteoarthritis were included. Patients who underwent arthroscopic
debridement or did not meet the MSIS criteria were excluded.
The following clinical variables were collected: sex, age, BMI, comorbidities, medication,
inflammatory markers and specifications of index surgery and the DAIR procedure. BMI was
measured during the preoperative anesthetic screening prior to joint arthroplasty surgery.
Patients were categorized according to BMI, with a cut-off value of 30kg/m2 (i.e. class 1 obe-
sity) and 35kg/m2 (i.e. class 2 obesity / severe obesity) [1, 18]. Early failure was defined as the
need for 1) a second DAIR procedure, 2) revision arthroplasty or definitive implant removal,
3) infection-related death or 4) suppressive antimicrobial treatment, all within 60 days after
initial debridement. Overall failure was defined as infection-related death or the need for
implant removal at any time point after initial debridement.
The following microbiological variables were collected: number of positive cultures, type of
microorganism and resistance patterns of cultured microorganisms.
Index surgery and DAIR procedure
Prior to joint arthroplasty patients performed a whole-body cleansing with chlorhexidine
scrub. In case of abundant hair growth on the knee or groin region, hair was removed from
the surgical site by use of a clipper. Prior to surgical incision, the skin was disinfected with a
solution of povidone tincture in 75% alcohol. In case patients were allergic to povidone, the
skin was disinfected by a chlorhexidine-alcohol solution. Cefazolin was administered as antibi-
otic prophylaxis 30 to 60 minutes prior to incision. According to local protocol, cefazolin dos-
age was one gram for patients <80kg and two grams for patients�80kg. In all patients
receiving total hip arthroplasty the posterolateral approach was used. Total knee arthroplasties
were inserted via the medial parapatellar approach. The incisions were closed with staples and
dressed with absorbent bandages. In case of wound leakage in the postoperative period a pres-
sure bandage was applied.
DAIR procedure consisted of opening the wound via the pre-existing incision, excising
hematoma and avital tissue and irrigating the wound thoroughly with three to six liters of
saline. Modular components were exchanged and optionally gentamicin-impregnated beads
or sponges were inserted into the joint cavity according to local protocol and clinical judge-
ment of the operating orthopaedic surgeon. Multiple cultures of deep tissue and synovial fluid
were obtained during debridement. Cefuroxime was started as empirical intravenous antimi-
crobial treatment after obtaining cultures and was adjusted according to the culture results.
Intravenous antimicrobial treatment was continued for at least two weeks before switching to
an oral regimen, which was continued for an additional ten weeks. Rifampin was added to the
antimicrobial treatment regimen in infections caused by rifampin-susceptible staphylococci.
Statistical analysis
Categorical variables were presented in absolute frequencies and percentages. Continuous var-
iables were expressed as mean and standard deviation (SD) or as median and interquartile
range (IQR) when not normally distributed according to the Kolmogorov-Smirnov test of nor-
mality. The statistical comparison of categorical variables was performed using the Chi-square
test. Parametric continuous variables were compared using the Student’s t-test and one-way
ANOVA. Non-parametric continuous variables were compared with the Mann-Whitney U
test. Statistical significance was defined as a two-tailed p<0.05. Statistical assessment was car-
ried out with IBM SPSS Statistics (version 24.0, Chicago, USA).
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A total of 356 patients with early PJI of the knee or hip treated with DAIR were identified. We
excluded 52 patients with revision arthroplasties and 67 patients with primary arthroplasties
placed for other indications than osteoarthritis (fracture (n = 62), rheumatoid arthritis (n = 2)
and malignancy (n = 3)). A total of 237 included patients had a mean age of 71.3 years (SD
10.5, range 27–91 years) and 63.7% of patients (n = 151) were female. 160 patients (67.5%) had
a periprosthetic hip infection and 77 patients (32.5%) had a periprosthetic knee infection.
Patients experienced a mean duration of symptoms of infection of 6.8 days (SD 5.9, range
1–21 days) before DAIR procedure. DAIR procedure was performed at a mean of 20.7 days
(SD 11.7, range 7–74 days) after index surgery. The median follow-up was 1.7 years (IQR 1.0–
3.3) and was similar in obese and non-obese patients (1.8 years (IQR 1.0–3.1) vs 1.5 years (IQR
1.0–3.4), p = 0.732).
From the included cohort (n = 237) a total of 126 patients (53.2%) were obese. Of these
obese patients 62 were severely obese (49.2%). Non-obese, obese and severely obese patients
were of similar age (72.3 years vs 70.5 years vs 69.4 years, p = 0.229), while severely obese
patients were more often of female gender than non-severely obese patients (74.2% vs 60.0%,
p = 0.046). Regarding comorbidities, both obese and severely obese patients had a higher inci-
dence of hypertension compared with non-obese patients and non-severely obese patients
respectively (69.0% vs 56.8%, p = 0.050 and 75.8% vs 58.9%, p = 0.017), while diabetes mellitus
only had a higher incidence in severely obese patients (35.5% vs 17.1%, p = 0.003). Regarding
symptoms at initial DAIR, severely obese patients had a higher incidence of redness of the
wound compared with non-severely obese patients (39.4% vs 56.5%, p = 0.020). There was a
trend towards more wound leakage in obese patients, but this difference was not statistically
significant (82.0% vs 89.7%, p = 0.088) (Table 1).
Comparing the variables of the joint replacement surgery and DAIR procedure we did not
find any differences between non-obese, obese and severely obese patients (Table 1). Regard-
ing the outcome after DAIR, rates of early failure and overall failure were comparable between
non-obese, obese and severely obese patients (30.6% vs 33.3% vs 30.6%, p = 0.740 and 9.0% vs
10.3% vs 9.7%, p = 0.961 respectively). In the majority of patients (n = 67, 88.2%) early failure
was due to the need for a second DAIR, five patients (6.6%) needed revision surgery and two
patients (2.6%) started with suppressive antimicrobial treatment after initial debridement.
Microbiological characteristics
Overall, early PJIs were polymicrobial in 113 patients (47.7%). Predominant microorganisms
causing the infection were Staphylococcus aureus (44.3%), Staphylococcus epidermidis (34.6%),
Streptococcus species (21.5%) and Enterococcus species (19.8%). Regarding polymicrobial
infections, 66.4% solely involved Gram-positive microorganisms (n = 75), 2.7% solely Gram-
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negative microorganisms (n = 3), and 31.0% involved both Gram-positive and Gram-negative
microorganisms (n = 35). In patients with polymicrobial infections, each obtained culture was
positive in 86.7% of cases (n = 98). The mean number of species cultured in these polymicro-
bial infections was 2.64 (range 2–7), with 2 species being cultured in 56.6% (n = 64), 3 species
in 30.1% (n = 34), 4 species in 8.0% (n = 9), 5 species in 4.4% (n = 5) and 7 species in 0.9%
(n = 1). In case of a polymicrobial infection, Staphylococcus epidermidis was involved in 46.0%
of cases, Staphylococcus aureus in 41.6%, Enterococcus species in 38.1%, Streptococcus species
in 29.2% and Proteus species in 10.6%. The most common combination of microorganisms
was Staphylococcus aureus together with Streptococcus species (n = 7) and Staphylococcus epi-
dermidis together with Enterococcus species (n = 6).
Obese patients had a higher rate of polymicrobial infections than non-obese patients
(60.3% vs 33.3%, p<0.001), with higher prevalence of Enterococcus species (27.0% vs 11.7%,
p = 0.003). The same applies to severely obese patients compared with non-severely obese
patients (polymicrobial infections in 59.7% vs 43.4%, p = 0.028 and Enterococcus species in
32.2% vs 15.4%, p = 0.004). Overall, there were no differences regarding Gram-negative micro-
organisms between obese and non-obese patients, but there were significantly more infections
caused by Proteus species in severely obese patients compared with non-severely obese patients
(12.9% vs 2.3%, p = 0.001).
Table 1. Clinical characteristics of early PJIs according to BMI.
Variables BMI <30 (n = 111) BMI�30 (n = 126) P value BMI <35 (n = 175) BMI�35 (n = 62) P value
Sex Male 43 (38.7%) 43 (34.1%) .461 70 (40.0%) 16 (25.8%) .046
Age in years Mean (SD) 72.3 (11.7) 70.5 (9.2) .192 72.0 (10.8) 69.4 (9.3) .098
Comorbidities Diabetes Mellitus 20 (18.0%) 32 (25.4%) .171 30 (17.1%) 22 (35.5%) .003
Hypertension 63 (56.8%) 87 (69.0%) .050 103 (58.9%) 47 (75.8%) .017
Ischaemic heart disease 17 (15.3%) 23 (18.3%) .547 33 (18.9%) 7 (11.3%) .172
COPD 17 (15.3%) 28 (22.2%) .176 30 (17.1%) 15 (24.2%) .224
Medication Anticoagulants 24 (21.6%) 24 (19.0%) .623 36 (20.6%) 12 (19.4%) .838
Corticosteroids 18 (16.2%) 10 (7.9%) .049 22 (12.6%) 6 (9.7%) .544
Smoker 19 (18.3%) 18 (15.0%) .511 28 (17.1%) 9 (15.0%) .711
Serum inflammatory markers Leukocyte count, x 109/L 12.3 (5.5) 10.4 (3.8) .002 11.4 (5.0) 10.8 (3.9) .392
CRP, mg/L 92.9 (96.1) 83.1 (98.9) .439 86.7 (94.7) 90.4 (106.0) .797
Symptoms Wound leakage 91 (82.0%) 113 (89.7%) .088 148 (84.6%) 56 (90.3%) .261
Redness 44 (39.6%) 60 (47.6%) .217 69 (39.4%) 35 (56.5%) .020
Fever 25 (22.5%) 21 (16.7%) .255 33 (18.9%) 13 (21.0%) .718
Joint Hip 79 (71.8%) 81 (64.8%) .342 122 (70.5%) 38 (61.3%) .473
Knee 32 (28.2%) 45 (35.2%) 51 (29.5%) 24 (38.7%)
Cementation No cement 24 (21.6%) 21 (16.7%) .354 37 (21.1%) 8 (12.9%) .295
Cement without antibiotics 4 (3.6%) 2 (1.6%) 5 (2.9%) 1 (1.6%)
Cement with antibiotics 83 (74.8%) 103 (81.7%) 133 (76.0%) 53 (85.5%)
Drain No drain 25 (22.9%) 32 (25.6%) .065 41 (23.7%) 16 (26.2%) .906
1 drain 38 (34.9%) 58 (46.4%) 71 (41.0%) 25 (41.0%)
2 drains 46 (42.2%) 35 (28.0%) 61 (35.3%) 20 (32.8%)
Number of DAIRs Mean (SD) 1.28 (0.49) 1.31 (0.48) .632 1.29 (0.48) 1.31 (0.50) .834
Exchange of components 29 (26.4%) 32 (25.4%) .866 49 (28.2%) 12 (19.4%) .174
DAIR failure Early failure 34 (30.6%) 42 (33.3%) .656 57 (32.6%) 19 (30.6%) .780
Overall failure 10 (9.0%) 13 (10.3%) .734 17 (9.7%) 6 (9.7%) .993
Bold indicates statistically significant differences. BMI: body mass index; COPD: chronic obstructive pulmonary disease; CRP: C-reactive protein; DAIR: debridement,
antibiotics and implant retention; SD: standard deviation
https://doi.org/10.1371/journal.pone.0215035.t001
Polymicrobial and Gram-negative periprosthetic joint infections of the hip in obese patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0215035 April 8, 2019 5 / 11
Analyzing patients with PJI of the hip and knee separately, we found that the higher rate of
polymicrobial infections in obese patients, including Enterococcus species and Gram-negative
microorganisms, was only significant in patients with periprosthetic hip infections (Table 2).
Gram-negative rods were isolated in 34.2% of severely obese patients with hip PJI, compared
with 24.7% in obese patients and 12.7% in non-obese patients (p = 0.018). Proteus species were
the main isolated Gram-negative microorganism, with a higher rate in severely obese patients
compared with non-severely obese patients (18.4% vs 1.6%, p<0.001). Moreover, Morganella
morganii was more often involved in severely obese patients (7.9% vs 0.0%, p = 0.002). These
differences were not significant in obese patients compared with non-obese patients. Assess-
ment of the microbiological characteristics in patients with periprosthetic knee infections only
showed a significant higher rate of involvement of Enterococcus faecium in severely obese com-
pared with non-severely obese patients (8.3% vs 0.0%, p = 0.037). There were no other signifi-
cant differences between non-obese, obese and severely obese patients (Table 3).
Regarding the susceptibility analyses of cefazolin and cefuroxime in Gram-negative micro-
organisms, results of these tests were only partially available. Microorganisms that are intrinsi-
cally resistant to cefazolin and cefuroxime (such as Enterococcus species, Enterobacter cloacae,
Proteus vulgaris and Morganella morganii) are not indicated. E. coli was sensitive to cefazolin
in all tested cases (n = 3). Proteus mirabilis showed intermediate resistance to cefazolin in
Table 2. Isolated microorganisms during DAIR in early PJIs of the hip according to BMI.
Variables BMI <30 (n = 79) BMI�30 (n = 81) P value BMI <35 (n = 122) BMI�35 (n = 38) P value
Percentage of positive
cultures
Mean (SD) 91.4 (20.1) 91.8 (18.5) .917 90.7 (20.9) 94.4 (12.2) .304
Polymicrobial infection 27 (34.2%) 55 (67.9%) <0.001 56 (45.9%) 26 (68.4%) .015
Gram-positive
microorganisms
76 (96.2%) 78 (96.3%) .975 117 (95.9%) 37 (97.4%) .678
Staphylococcus aureus 33 (41.8%) 32 (39.5%) .770 51 (41.8%) 14 (36.8%) .587
Staphylococcus epidermidis 25 (31.6%) 35 (43.2%) .131 43 (35.2%) 17 (44.7%) .291
Corynebacterium species 7 (8.9%) 20 (24.7%) .008 22 (18.0%) 5 (13.2%) .484
Enterococcus species 10 (12.7%) 24 (29.6%) .009 20 (16.4%) 14 (36.8%) .007
Enterococcus faecalis 7 (8.9%) 20 (24.7%) .008 16 (13.1%) 11 (28.9%) .023
Enterococcus faecium 1 (1.3%) 0 (0.0%) .310 1 (0.8%) 0 (0.0%) .576
Streptococcus species 20 (25.3%) 16 (19.8%) .399 32 (26.2%) 4 (10.5%) .043
Other gram-positivesa 3 (3.8%) 3 (3.7%) .975 4 (3.3%) 2 (5.3%) .574
Gram-negative
microorganisms
10 (12.7%) 20 (24.7%) .051 17 (13.9%) 13 (34.2%) .005
Enterobacteriaceae Escherichia coli 2 (2.5%) 3 (3.7%) .670 3 (2.5%) 2 (5.3%) .386
Enterobacter cloacae 2 (2.5%) 3 (3.7%) .670 3 (2.5%) 2 (5.3%) .386
Proteus speciesb 2 (2.5%) 7 (8.6%) .094 2 (1.6%) 7 (18.4%) < .001
Klebsiella species 1 (1.3%) 0 (0.0%) .310 1 (0.8%) 0 (0.0%) .576
Morganella morganii 0 (0.0%) 3 (3.7%) .084 0 (0.0%) 3 (7.9%) .002
Non-fermenters Pseudomonas species 3 (3.8%) 3 (3.7%) .975 5 (4.1%) 1 (2.6%) .678
Acinetobacter species 1 (1.3%) 2 (2.5%) .575 2 (1.6%) 1 (2.6%) .694
Anaerobe
microorganisms
3 (3.8%) 4 (4.9%) .724 4 (3.3%) 3 (7.9%) .224
Candida species 0 (0.0%) 1 (1.2%) .322 0 (0.0%) 1 (2.6%) .072
Bold indicates statistically significant differences. BMI: body mass index; SD: standard deviation.
a Micrococcus luteus (n = 2), Microbacterium flavescens (n = 1), Dolosigranulum pigrum (n = 1), Kocuria species (n = 1), Rothia mucilaginosa (n = 1).
b 8/9 Proteus species that were isolated were Proteus mirabilis, 1/9 was Proteus vulgaris.
https://doi.org/10.1371/journal.pone.0215035.t002
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33.3% (n = 3). Regarding cefuroxime, E. coli (n = 6), Klebsiella species (n = 1) and Proteus
mirabilis (n = 11) all showed 100% sensitivity.
Discussion
This study describes the differences in clinical and microbiological characteristics of early PJI
between non-obese, obese and severely obese patients. Our results demonstrated that obese
and severely obese patients with periprosthetic hip infections had higher rates of polymicrobial
infections with involvement of Enterococcus species. Moreover, severely obese patients with
PJI of the hip had a higher rate of infections with Gram-negative microorganisms than non-
severely obese patients. Interestingly, these results were not found in obese patients with peri-
prosthetic knee infections, which indicates that infections of the hip and knee should be per-
ceived as two separate entities and should therefore be approached differently. Even though
the outcome after DAIR was comparable between non-obese, obese and severely obese
patients, the differences in microbiological profile between obese and non-obese patients indi-
cate that preventive measures should be adapted for hip arthroplasty surgery in obese patients.
The concept of abundant colonization with multiple microorganisms in the hip region [14,
15] is expected to mainly apply to direct anterior incisions, as previously described in literature
[19, 20]. Interestingly, in our cohort obese patients showed abundant colonization with multi-
ple microorganisms as well, even though posterolateral incisions were used for implantation of
Table 3. Isolated microorganisms in early PJIs of the knee according to BMI.
Variables BMI <30 (n = 31) BMI�30 (n = 44) P value BMI <35 (n = 51) BMI�35 (n = 24) P value
Percentage of positive
cultures
Mean (SD) 85.3 (30.1) 91.3 (22.0) .318 86.5 (28.3) 93.8 (18.3) .251
Polymicrobial infection 9 (29.0%) 20 (45.5%) .150 18 (35.3%) 11 (45.8%) .382
Gram-positive
microorganisms
27 (87.1%) 42 (95.5%) .189 46 (90.2%) 23 (95.8%) .401
Staphylococcus aureus 15 (48.4%) 24 (54.5%) .599 26 (51.0%) 13 (54.2%) .797
Staphylococcus epidermidis 8 (25.8%) 14 (31.8%) .573 15 (25.5%) 9 (37.5%) .287
Corynebacterium species 3 (9.7%) 5 (11.4%) .816 5 (9.8%) 3 (12.5%) .724
Enterococcus species 3 (9.7%) 10 (22.7%) .142 7 (13.7%) 6 (25.0%) .229
Enterococcus faecalis 2 (6.5%) 5 (11.4%) .471 5 (9.8%) 2 (8.3%) .838
Enterococcus faecium 0 (0.0%) 2 (4.5%) .229 0 (0.0%) 2 (8.3%) .037
Streptococcus species 6 (19.4%) 9 (20.5%) .907 12 (23.5%) 3 (12.5%) .265
Other gram-positivesa 1 (3.2%) 2 (4.5%) .774 2 (3.9%) 1 (4.2%) .960
Gram-negative
microorganisms
4 (12.9%) 7 (15.9%) .717 8 (15.7%) 3 (12.5%) .716
Enterobacteriaceae Escherichia coli 0 (0.0%) 1 (2.3%) .398 1 (2.0%) 0 (0.0%) .490
Enterobacter cloacae 2 (6.5%) 2 (4.5%) .718 3 (5.9%) 1 (4.2%) .758
Proteus mirabilis 1 (3.2%) 2 (4.5%) .774 2 (3.9%) 1 (4.2%) .960
Klebsiella species 0 (0.0%) 0 (0.0%) 1.000 0 (0.0%) 0 (0.0%) 1.000
Morganella morganii 0 (0.0%) 0 (0.0%) 1.000 0 (0.0%) 0 (0.0%) 1.000
Non-fermenters Pseudomonas species 1 (3.2%) 1 (2.3%) .801 1 (2.0%) 1 (4.2%) .580
Acinetobacter species 0 (0.0%) 1 (2.3%) .398 1 (2.0%) 0 (0.0%) .490
Anaerobe
microorganisms
0 (0.0%) 1 (2.3%) .398 1 (2.0%) 0 (0.0%) .490
Candida species 0 (0.0%) 0 (0.0%) 1.000 0 (0.0%) 0 (0.0%) 1.000
Bold indicates statistically significant differences. BMI: body mass index; SD: standard deviation.
a Granulicatella adiacens (n = 2), Staphylococcus lugdunensis (n = 1)
https://doi.org/10.1371/journal.pone.0215035.t003
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the hip arthroplasties. Contamination of the wound can occur primarily during surgery or sec-
ondarily in the postoperative period. Primary contamination may occur if inadequate antibiotic
prophylaxis is applied (either by insufficient dosage or inadequate type of antibiotics) or if the
hip region is not thoroughly disinfected. The latter may be prevented by more thorough disin-
fection of the hip region, for example by using chlorhexidine-alcohol as a local disinfectant.
Even though there are no large trials comparing chlorhexidine-alcohol with povidone tincture
in 75% alcohol, it is proven that chlorhexidine-alcohol is more effective than povidone-iodine
in reducing postoperative infections [21]. This superior protection is mainly attributed to a
reduction in Gram-positive skin flora by rapid action and persistent activity despite exposure to
bodily fluids [21]. Nevertheless, there was a high number of polymicrobial infections in our
cohort, caused by microorganisms susceptible to the local disinfectant as well as the antimicro-
bial prophylaxis. This may indicate that either the antibiotic dosage was too low or that a signifi-
cant proportion of PJIs developed due to secondary contamination in the postoperative period,
maybe due to prolonged wound leakage, via the retrograde pathway [22]. Although our data
showed a trend towards a higher rate of wound leakage in obese patients, this difference was
not statistically significant. To prevent secondary contamination, it is important to provide ade-
quate wound care with sterile absorbent dressings and pressure bandages [23]. Therefore, obese
patients should be evaluated more extensively after joint arthroplasty, to detect wound compli-
cations and provide adequate wound care at an early time point.
A different option for improving preventive measures in obese patients receiving total hip
arthroplasty is to increase the dosage of cefazolin, especially since previous studies showed that
the currently applied cefazolin dosage as antibiotic prophylaxis may not be sufficient to achieve
adequate tissue concentrations in obese patients [11–13]. Another reason to increase the dos-
age of cefazolin is the higher rate of infections caused by Proteus species in obese patients in
our cohort, since Proteus species have a higher minimum inhibitory concentration for cefazo-
lin than other Enterobacteriaceae [24]. Recently the Dutch guideline for antibiotic prophylaxis
was adjusted, in which it is now advised to administer three grams of cefazolin in patients with
a BMI >40 kg/m2 [25], although our results suggest that this higher dosage may also be benefi-
cial for patients with a BMI>35 kg/m2.
Another option is to broaden the antibiotic prophylaxis during total hip arthroplasty sur-
gery in obese patients, especially since cefazolin does not cover for Enterococcus species and
most of the Gram-negative rods [26]. Broadening the prophylaxis to cefuroxime combined
with vancomycin or teicoplanin may be an option. Previous studies compared the efficacy of
various antibiotic prophylaxis regimens in reducing infection rates after joint arthroplasty,
mostly by adding an antibiotic agent with a broader Gram-positive spectrum (such as a glyco-
peptide). Two studies compared the efficacy of cefazolin with a combined regimen of cefazolin
and vancomycin [27, 28]. Liu et al. found a reduction in infections in the combined regimen
group [27], while Sewick et al. did not detect a difference between the regimens [28]. Other
studies compared the use of cefuroxime and a combined regimen of cefuroxime and teicopla-
nin and found a reduced infection rate in the combined treatment group [29, 30]. The higher
efficacy of the combined regimens in these studies was mainly based on a reduction in infec-
tions caused by methicillin-resistant Staphylococcus aureus.
Tornero et al. studied the efficacy of dual prophylaxis (cefuroxime plus teicoplanin) and
found a reduction in PJI rate solely in obese patients when adding teicoplanin to the antimi-
crobial regimen [30]. This reduction was mainly observed for PJI due to methicillin-suscepti-
ble Staphylococcus aureus, which supports the hypothesis that the dosage of antimicrobial
prophylaxis may be insufficient in obese patients, since methicillin-susceptible Staphylococcus
aureus should be fully covered by cefuroxime. A randomized controlled trial is needed to pro-
vide conclusive scientific evidence regarding the most effective antibiotic prophylaxis regimen
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for obese patients. This randomized trial should compare different antibiotic regimens and
should show whether the absolute percentage of PJIs indeed decreases when adapting the anti-
biotic prophylaxis regimen in obese patients receiving total hip arthroplasty.
There are several limitations to our study. First of all, we merely included patients with early
PJI treated with DAIR. We did not include chronic infections, which could have provided addi-
tional insights, as these patients may have different microbiological profiles. We did not collect
data on the total number of joint arthroplasties implanted in the participating hospitals during
the study period. Therefore, we do not know the exact incidence of PJI in our cohort. However,
previous studies clearly demonstrated a higher rate of PJI in obese patients [6, 7], and therefore,
it is likely that implementing the proposed prevention strategies will result in an absolute reduc-
tion of PJIs in the obese population. A second limitation is the retrospective design of this study.
However, due to thorough recording of clinical and microbiological findings in the electronic
patient files of patients with PJI there were few missing variables, by which the results are repre-
sentative for the included patients. Finally, we did not collect data on the exact disinfective
agent that has been applied prior to surgery, because we could not reliably collect the allergies of
included patients. However, in consultation with the orthopaedic surgeons in the participating
hospitals we are confident that the disinfection procedure has been carried out correctly in each
patient, whether with a povidone-alcohol solution or with a chlorhexidine-alcohol solution.
A strength of this study is that we were able to select a large homogenous group of patients
with early PJI. Our initial statistical analyses showed that non-obese patients had a significantly
higher rate of arthroplasties indicated for fracture than obese patients (27.6% vs 10.6%,
p<0.001, S1 File). Since literature indicates that fracture-related PJIs have a lower rate of
Gram-negative infections and a higher failure rate compared with primary PJIs [31], we
decided to only analyze patients with primary arthroplasties indicated for osteoarthritis.
In conclusion, obese and severely obese patients with early periprosthetic hip infections
have higher rates of polymicrobial infections with involvement of enterococci and Gram-nega-
tive rods, which emphasizes the importance of improving preventive strategies in this specific
patient category.
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